Villers-lès-Nancy, 12 May 2025 - 6:00 PM (CET) PRESS RELEASE Q1 revenue at 31 March 2025: €57.0m+ 6.9% growth on a reported basis and + 5.9% like-for-like Q1 2025 REVENUE (€m)2024Reported basis2025Reported basisChange /Reported basisOf which external growthLike-for-like change(organic growth)Equasens Group 53.357.03.7<td style="width:79.4px;;text-align: center ; vertical-align: middle; border-top: solid ...

Villers-lès-Nancy, 30 April 2025 - 8:00 AM (CET) PRESS RELEASE EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR TO ACQUIRE TWO SOFTWARE PUBLISHING BUSINESSES OPERATING IN THE PUBLIC HEALTH SECTOR Project for a targeted acquisition in the public health sector: Acquisition of Novaprove, publisher of the ResUrgences software, Acquisition of the DIS business assets, Strategic reinforcement of Equasens Group's Axigate Link division in this market segment *** Equasens Group (Euronext Paris™ - Co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 814-00098 (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2024 EQUUS TOTAL RETURN, INC. (Exact name of registrant as specified in its charter) __________________________________________ (former address, ...

Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment efforts: Revenue: €216.8m (-1.4%)Current Operating Income: €45.1m (-19.2%) Net profit attributable to Group shareholders: €36.2m (-23.0%) At the same time, profit margins remained high, and even improved over the year: Current operating income / Revenue: 20.8% on a reported basis (H1: 19.3% and H2: 22.3%)So ...

Villers-lès-Nancy, 6 February 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like) Revenue (€&)2023Reported basis2024Reported basisChange /Reported basisOf which external growthOf which Ségur1 2024Of which Ségur 2023Like-for-like change(organic growth)Q156.2<td style="width:75.6px;;text-align: right ; vertical-align: ...

HOUSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE:EQS) ("Equus" or the "Fund") today announces that Fraser Atkinson has been appointed as the Fund's independent Chairman of the Board and that John J. May has been appointed as an independent director, each with immediate effect. Mr. Atkinson will continue to serve as Chair of the Equus Audit Committee, and as a member of Fund's Compensation Committee and Governance and Nominating Committee. Mr. May has been a practicing Chartered Acco ...

Acquisition Overview - Equasens Group acquires a 90% majority stake in Calimed SAS, a cloud-based medical Practice Management Software (PMS) provider, to strengthen its position in the French healthcare software market [15][1] - Calimed will become part of Equasens' Medical Solutions Division, which already serves over 25,000 users with a comprehensive range of software solutions for medical and paramedical professions [5][16] Strategic Goals - The acquisition aims to increase Equasens' market share in the French PMS market and expand its portfolio of online solutions to support the digital transition of medical practices [1] - Equasens plans to integrate Calimed's innovative modules, such as "Follow-Up" for pre-, per-, and post-operative monitoring, into its existing software range [6] - The company aims to establish easy-care as the market-leading software by leveraging synergies between Calimed and Equasens' existing solutions [21] Market Potential - The French private medical practice software market is fragmented, with significant potential for consolidation, and Equasens' Medical Solutions Division is currently the third-largest player [8] - There are 200,000 practitioners in France, including 115,000 in private practice, indicating considerable growth potential for Equasens' solutions [8] Product Innovations - Calimed's software features advanced pre-, per-, and post-operative questionnaire management and automatic data integration into Electronic Patient Records, offering time savings for surgeons [2] - Equasens plans to integrate innovative modules like the AI Loquii voice consultation assistant and PandaLab Pro inter-professional messaging system into the easy-care solution [6] - Starting in 2025, Calimed users will gain access to new digital services, such as digital prescriptions, through a gateway between Calimed and easy-care [9] Synergies and Growth - Calimed's business model is based on recurring SaaS subscription revenues, with nearly 4,000 active users and excellent customer retention rates [3] - Equasens will leverage its Private Health Cloud infrastructure, certified for hosting healthcare data, to enhance Calimed's offerings [7] - The acquisition will enable Equasens to accelerate the deployment of easy-care and recruit new clients more effectively, starting in 2025 [6] Industry Trends - The healthcare system is undergoing a digital transformation, with digital solutions emerging as a key lever for cost optimization, streamlined care pathways, and improved coordination between professionals [19] - New regulations are driving innovation and investment in open, secure, and interoperable healthcare solutions [19] Company Background - Equasens Group, founded over 35 years ago, employs over 1,300 people across Europe and is a leader in digital healthcare solutions [11] - The company's mission is to facilitate the day-to-day work of healthcare professionals through professional software, applications, and digital solutions [11]

HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) reports net assets as of September 30, 2024, of $40.2 million. Net asset value per share decreased to $2.96 as of September 30, 2024, from $3.66 as of June 30, 2024. Comparative data is summarized below (in thousands, except per share amounts):   As of the Quarter Ended9/30/20246/30/20243/31/202412/31/20239/30/2023Net assets$40,165$49,792$45,892$48,287$47,128Shares outstanding13,58613,58613,58613,58613 ...

Investment Strategy - Equus Total Return, Inc. aims to maximize stockholder returns through capital appreciation and current income by investing in companies with a total enterprise value between $5.0 million and $75.0 million [172]. - Equus Energy plans to secure equity or debt financing, request operators to shut-in wells, or sell oil and gas holdings to conserve cash resources [181]. Economic Indicators - As of September 30, 2024, crude oil prices were $68.27 per barrel, while natural gas prices finished the first nine months of 2024 at $2.92 per MMBTU [180]. - The U.S. GDP increased at an annualized rate of 2.8% in Q3 2024, with projections of 2.6% growth for the entire year [183]. - The Conference Board projects a GDP increase of 1.7% for 2025, indicating a slowdown in economic growth [183]. - The unemployment rate in the U.S. held steady at 4.1% as of October 2024, with no expected changes through 2025 [184]. Financial Performance - As of September 30, 2024, the company's net asset value decreased from $3.55 per share to $2.96 per share, a decline of 16.6% [189]. - The common stock is trading at a 54.1% discount to net asset value, compared to 59.2% as of December 31, 2023 [189]. - Total investment income for the nine months ended September 30, 2024, was $0.9 million, up from $0.06 million in the same period of 2023 [199]. - Net investment loss remained relatively unchanged at $2.7 million for the nine months ended September 30, 2024, compared to $3.1 million in 2023 [198]. - During the nine months ended September 30, 2024, the company made a $2.2 million follow-on debt investment in Morgan E&P, LLC, while recording a $3.6 million decrease in the fair value of its equity holding in Morgan [203]. - The company recorded a $2.0 million decrease in the fair value of its investment in Equus Energy, LLC, primarily due to declining oil prices [204]. Expenses and Compensation - Compensation expense decreased to $1.3 million for the nine months ended September 30, 2024, from $1.5 million in 2023, attributed to bonuses paid in 2023 [200]. - Professional fees increased to $1.2 million for the nine months ended September 30, 2024, compared to $0.7 million in 2023, due to overall fee increases in legal and accounting services [201]. Company Operations - The asset coverage ratio was reduced from 200% to 150%, allowing Equus to borrow up to twice the value of its net assets [176]. - The company has a wholly-owned Taxable Subsidiary to maintain its RIC status and avoid significant federal income taxes [173]. - The company is evaluating the impact of current market conditions on portfolio company valuations and their ability to provide current income [195]. - In October 2024, the company repaid its margin loan after the maturity of $55.0 million in U.S. Treasury Bills [207]. Equity Incentive Plan - The 2016 Equity Incentive Plan allows for the award of up to 2,434,728 shares of common stock to promote the interests of the Fund [177].

HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) ("Equus" or the "Company") reports net assets as of June 30, 2024, of $49.8 million. Net asset value per share increased to $3.66 as of June 30, 2024, from $3.38 as of March 31, 2024. Comparative data is summarized below (in thousands, except per share amounts): | --- | --- | --- | --- | --- | --- | |-------------------------|-----------|-----------|------------|-----------|-----------| | | | | | | | | As of the Quarter Ended | ...